1-3 of 3
J Kirkpatrick
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and safety of imatinib in adult patients with c-kit–positive acute myeloid leukemia

Clinical Trials & Observations
Thomas Kindler, Frank Breitenbuecher, Andreas Marx, Joachim Beck, Georg Hess, Birgit Weinkauf, Justus Duyster, Christian Peschel, Charles J. Kirkpatrick, Matthias Theobald, Harald Gschaidmeier, Christoph Huber, Thomas Fischer
Journal: Blood
Blood (2004) 103 (10): 3644–3654.
https://doi.org/10.1182/blood-2003-06-2071
Published: 2004
Journal Articles

Sustained complete hematologic remission after administration of the tyrosine kinase inhibitor imatinib mesylate in a patient with refractory, secondary AML

Clinical Trials & Observations Brief Report
Thomas Kindler, Frank Breitenbuecher, Andreas Marx, Georg Hess, Harald Gschaidmeier, Heinold Gamm, Charles J. Kirkpatrick, Christoph Huber, Thomas Fischer
Journal: Blood
Blood (2003) 101 (8): 2960–2962.
https://doi.org/10.1182/blood-2002-05-1469
Published: 2003
Journal Articles

Regulation of fibrinolysis by platelet-released plasminogen activator inhibitor 1: light scattering and ultrastructural examination of lysis of a model platelet-fibrin thrombus

JV Braaten, S Handt, WG Jerome, J Kirkpatrick, JC Lewis, RR Hantgan
Journal: Blood
Blood (1993) 81 (5): 1290–1299.
https://doi.org/10.1182/blood.V81.5.1290.1290
Published: 1993